0.640
+0.010
+(1.59%)
At close: 4:08:01 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,860,539
1,860,539
2,181,189
3,038,391
2,464,226
Cost of Revenue
564,895
564,895
693,608
607,903
549,777
Gross Profit
1,295,644
1,295,644
1,487,581
2,430,488
1,914,449
Operating Expense
1,487,129
1,487,129
2,041,789
1,782,809
1,465,582
Operating Income
-191,485
-191,485
-554,208
647,679
448,867
Net Non Operating Interest Income Expense
-121,429
-121,429
-64,382
46,597
127,511
Pretax Income
-161,260
-161,260
-2,122,778
496,013
765,844
Tax Provision
96,427
96,427
196,794
253,119
219,040
Net Income Common Stockholders
-54,017
-54,017
-1,914,918
416,509
473,382
Diluted NI Available to Com Stockholders
-54,017
-54,017
-1,914,918
416,509
473,382
Basic EPS
-0.01
--
-0.21
0.04
0.05
Diluted EPS
-0.01
--
-0.21
0.04
0.05
Basic Average Shares
9,297,073
--
9,329,999
9,431,297
9,465,682
Diluted Average Shares
9,297,073
--
9,336,768
9,487,676.538
9,465,682
Total Operating Income as Reported
161,698
161,698
-1,830,727
771,945
787,125
Total Expenses
2,052,024
2,052,024
2,735,397
2,390,712
2,015,359
Net Income from Continuing & Discontinued Operation
-54,017
-54,017
-1,914,918
416,509
473,382
Normalized Income
-174,833.750
-174,833.750
-883,906.250
474,354.750
395,268.869
Interest Income
147,908
147,908
146,794
163,948
135,728
Interest Expense
269,337
269,337
211,176
117,351
8,217
Net Interest Income
-121,429
-121,429
-64,382
46,597
127,511
EBIT
108,077
108,077
-1,911,602
613,364
774,061
EBITDA
334,310
334,310
-1,541,795
922,731
1,052,342
Reconciled Cost of Revenue
564,895
564,895
693,608
607,903
549,777
Reconciled Depreciation
226,233
226,233
369,807
309,367
278,281
Net Income from Continuing Operation Net Minority Interest
-54,017
-54,017
-1,951,214
426,633
508,299
Total Unusual Items Excluding Goodwill
161,089
161,089
-1,423,077
-63,629
158,308
Total Unusual Items
161,089
161,089
-1,423,077
-63,629
158,308
Normalized EBITDA
173,221
173,221
-118,718
986,360
894,034
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
40,272.250
40,272.250
-355,769.250
-15,907.250
45,277.869
12/31/2020 - 10/28/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2633.HK Jacobson Pharma Corporation Limited
1.250
-1.57%
600518.SS Kangmei Pharmaceutical Co., Ltd.
2.0100
-0.99%
1889.HK SANAI HEALTH GP
0.300
-1.64%
1011.HK NT PHARMA
0.280
+18.64%
3320.HK China Resources Pharmaceutical Group Limited
4.960
-1.20%
0570.HK TRAD CHI MED
1.960
+0.51%
2161.HK JBM (Healthcare) Limited
2.000
-3.38%
0013.HK HUTCHMED
22.550
-1.96%
6185.HK CanSino Biologics Inc.
30.500
+0.83%
HLN Haleon plc
10.11
+0.50%